Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Non-Small Cell Cancer of the Lung Utilizing Low-Dose Weekly Therapy of Taxotere and Carboplatin

NCT00003562 is registered in ClinicalTrials.gov with Hope Cancer Institute, Inc. as lead sponsor.

NCT NCT00003562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Non-Small Cell Cancer of the Lung Utilizing Low-Dose Weekly Therapy of Taxotere and Carboplatin
Lead sponsor
Hope Cancer Institute, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 1998
Completion date
Not reported
Enrollment
38 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer